Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines.

Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines.
复制标题

DOI:
10.1007/s00018-004-4255-0
复制
发表时间:
2004-09
期刊:
Cellular and molecular life sciences : CMLS
影响因子:
--
通讯作者:
Pascolo S
Pascolo S
中科院分区:
其他
文献类型:
--
作者:
Carralot JP;Probst J;Hoerr I;Scheel B;Teufel R;Jung G;Rammensee HG;Pascolo S

文献摘要

参考文献

被引文献

相似文献

在开发安全的基因疫​​苗接种策略的背景下,我们在小鼠中测试和研究了基于珠蛋白稳定的 mRNA 的疫苗接种。这种疫苗接种策略具有基因疫苗接种的优点(易于生产、对任何疾病的适应性以及冻干时储存成本低廉),但没有DNA疫苗接种的缺点(转基因的长期不受控制的表达、整合到宿主基因组中的可能性以及可能诱导抗DNA抗体)。 我们在这里报告,注射裸露的β-珠蛋白非翻译区(UTR)稳定的编码β-半乳糖苷酶的mRNA,然后在体内进行可检测的翻译。此外,我们还发现,这种疫苗接种策略可引发辅助性 T 2 (Th2) 型反应,在注射 mRNA 1 天后,通过应用重组粒细胞/巨噬细胞集落刺激因子,可以增强该反应并将其转变为 Th1 型免疫反应。我们的数据表明,给予球蛋白 UTR 稳定的 mRNA 是一种多功能的疫苗接种策略,可以进行操作以满足抗病毒、抗菌或抗肿瘤免疫的要求。
In the context of developing a safe genetic vaccination strategy we tested and studied globin-stabilized mRNA-based vaccination in mice. This vaccination strategy has the advantages of genetic vaccination (easy production, adaptability to any disease and inexpensive storage when lyophilized), but not the drawbacks of DNA vaccination (long-term uncontrolled expression of a transgene, possibility of integration into the host genome and possible induction of anti-DNA antibodies). We report here that injection of naked β-globin untranslated region (UTR)-stabilized mRNA coding for β-galactosidase is followed by detectable translation in vivo. In addition, we show that such a vaccination strategy primes a T helper 2 (Th2) type of response which can be enhanced and shifted to a Th1-type immune response by application of recombinant granulocyte/macrophage colony-stimulating factor 1 day after mRNA injection. Our data demonstrate that the administration of globin UTR-stabilized mRNA is a versatile vaccination strategy that can be manipulated to fit the requirement of antiviral, antibacterial or antitumor immunity.
DOI: 10.4049/jimmunol.164.6.3102
发表时间: 2000-03-15
影响因子: 4.4
作者:
Kusakabe, K;Xin, KQ;Okuda, K
通讯作者: Okuda, K
DOI: 10.1038/sj.gt.3301220
发表时间: 2000-07-01
期刊: GENE THERAPY
影响因子: 5.1
作者:
Schirrmacher, V;Förg, P;von Hoegen, P
通讯作者: von Hoegen, P
DOI: 10.1073/pnas.90.9.4156
发表时间: 1993-05-01
影响因子: 11.1
作者:
WANG, B;UGEN, KE;WEINER, DB
通讯作者: WEINER, DB
DOI: 10.1007/s00109-002-0395-6
发表时间: 2003-02-01
影响因子: 4.7
作者:
Kwissa, M;Kröger, A;Schirmbeck, R
通讯作者: Schirmbeck, R
DOI: 10.1016/s0264-410x(00)00438-2
发表时间: 2001-02-28
期刊: VACCINE
影响因子: 5.5
作者:
Vassilev, VB;Gil, LHVG;Donis, RO
通讯作者: Donis, RO